Skip to main content

Advertisement

Log in

HPLC Method Development, Validation and Application to Determining In-Vitro Effect of Levofloxacin on the Availability of Gliclazide

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A simple, accurate reversed-phase high-performance liquid chromatography (HPLC) method was developed and validated for simultaneous determination of gliclazide (GLZ) and fluoroquinolone antibacterial levofloxacin (LVO). The method was developed by using a stainless steel analytical column C18 (250 × 4.6 mm, 5 μm). The system was operated using a mobile phase consisting of methanol and phosphate buffer (pH 3.0) at a flow rate of 0.8 mL/min with ultraviolet (UV) detection at 228 nm wavelength. The proposed method was validated using ICH analytical method validation guidelines. Utilizing the HPLC technique, an assay was intended to determine in vitro effects of levofloxacin on sulphonyl urea based anti-diabetic drug gliclazide. The obtained results were further verified with UV spectrophotometric method. Availability of gliclazide was reduced in the presence of levofloxacin. These in vitro analyses confirmed that the co-administartion of gliclazide and levofloxacin may serve the foundation for designing further in vivo studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. S. E. Geerlings, A. I. Hoepelman, Immunol. Med. Microbiol., 26, 256 – 265 (1999).

    Article  Google Scholar 

  2. A. I. Hoepelman, E. Hak, K. J. Gorter, et al., Clin. Infect Dis., 41, 281 – 288 (2005).

    Article  PubMed  Google Scholar 

  3. K. J. Gorter, W. L. Goudzwaard, A. Y. Peleg, et al., Diabetes Metab.. Res. Rev., 23(3), 3 – 13 (2007).

    Google Scholar 

  4. R. Dougherty and L. V. Friedrich, J. Human Pharmacol. Drug Therapy, 24(1), 1807 – 1812 (2004).

    Google Scholar 

  5. E. Canseco and T. Kelesidis, Am. J. Med., 31(3), 122 – 134 (2009).

    Google Scholar 

  6. C. Aguirre, F. Cibrian, U. Lertxundi, and R. Hernandez, Eur. Geriatr. Med., 30(3), 181 – 183 (2012).

    Google Scholar 

  7. M. W. Pound and S. M. Miller, Am. J. Health-System Pharm., 1, 66 – 75 (2009).

    Google Scholar 

  8. L. Micheli, M. Sbrilli, and C. S. Nencini, Int. J. Clin. Pharmacol. Ther., 1, 50 – 55 (2012).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. S. Chhajed.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chhajed, S.S., Sonawnae, S.S., More, P.K. et al. HPLC Method Development, Validation and Application to Determining In-Vitro Effect of Levofloxacin on the Availability of Gliclazide. Pharm Chem J 57, 445–450 (2023). https://doi.org/10.1007/s11094-023-02903-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-023-02903-3

Keywords

Navigation